Safety and efficacy of low-dose aspirin in ischemic stroke patients with different G6PD conditions.

Yicong ChenJianle LiZilin OuYusheng ZhangZhijian LiangWeisheng DengWeixian HuangZhengdong WuHaihong JiangQinghua LiuFubing OuyangShihui XingJinsheng Zeng

Published in: International journal of stroke : official journal of the International Stroke Society (2020)

Long-term low-dose aspirin therapy might relate to worse safety outcomes in patients with glucose-6-phosphate dehydrogenase deficiency and large clinical trials are needed to further confirm these findings.

Keyphrases

low dose
clinical trial
high dose
atrial fibrillation
blood glucose
phase ii
stem cells
cardiovascular disease
type diabetes
mesenchymal stem cells
blood pressure
coronary artery disease
skeletal muscle
adipose tissue
insulin resistance